Clinical Trials Browser

Recruiting × INDUSTRY × Androgen Antagonists × Clear all

NCT06952803 2026-04-21

EvoPAR-PR02

Phase 3 Recruiting

Prostatic Neoplasms

NCT06661122 2026-04-20

HAYATE

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)